Conceivably, the influence of the αvβ3 integrin in breast cancer cells extends beyond its function as a membrane thyroid hormone receptor and is mediated through other ligands of the extracellular matrix, such as the canonical ligand vitronectin [84]. Here, VTN is linked to breast carcinoma.